Increasing Diabetes Management Demands Boost Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Market is projected to reach $31.41 billion by 2031, at a CAGR of 15% during the forecast period 2024–2031. 

Meticulous Research®, a renowned global market research company, has published a comprehensive report titled, ‘Continuous Glucose Monitoring Market Size, Share, Forecast, & Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics) – Global Forecast to 2031.’

Download Complete Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5960

According to the report, the global continuous glucose monitoring (CGM) market is forecasted to reach $31.41 billion by 2031, growing at a compound annual growth rate (CAGR) of 15% from 2024 to 2031. This growth is primarily attributed to the rising prevalence of diabetes, an increase in sedentary lifestyles, the advantages of CGM over traditional glucose monitoring methods, and the growing popularity of CGM among athletes and fitness enthusiasts. Additionally, advancements in CGM technology, the shift towards personalized care, heightened health awareness, and increasing accessibility to diabetes care devices in low- and middle-income countries are expected to create significant growth opportunities for market participants.

Key Players

The report offers a detailed analysis of the key players in the market, covering their product portfolios, geographic presence, and strategic developments over the past three to four years. The continuous glucose monitoring market has seen various organic and inorganic developments recently. Leading companies in this space include:

• DexCom, Inc. (U.S.)
• Abbott Laboratories (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Medtronic plc (Ireland)
• Nemaura Medical Inc. (U.K.)
• LifeScan, Inc. (U.S.)
• Senseonics Holdings, Inc. (Maryland)
• A. Menarini Diagnostics S.r.l (Italy)
• Medtrum Technologies, Inc. (China)
• B. Braun Melsungen SE (Germany)

Market Segmentation

The CGM market is segmented by component, age group, end user, and geography:

• By Component:
  • Sensors (Disposable, Implantable)
  • Transmitters
  • Receivers

  In 2024, the sensors segment is expected to dominate the market, accounting for 52.4% of the overall CGM market. This is primarily due to advancements in sensor technology, the availability of disposable sensors, increased adoption of CGM over traditional glucometers, and the rising incidence of diabetes. Frequent sensor replacements also contribute to the large market share.

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/continuous-glucose-monitoring-market-5960

• By Age Group:
  • Adults
  • Children

  The adult segment is projected to hold the largest market share in 2024, driven by the high prevalence of diabetes among adults, increasing adoption of wearable health devices, and a growing focus on preventive healthcare. The adult population has a higher incidence of diabetes compared to children, leading to greater demand for CGM devices in this age group.

• By End User:
  • Homecare Settings
  • Hospitals & Clinics

  The homecare settings segment is expected to account for over 82.3% of the market in 2024. Factors driving this growth include the increasing elderly population, the growing burden of diabetes, and the demand for self-monitoring solutions. CGM devices for home use offer benefits such as ease of accessibility, reduced time for travel to healthcare facilities, and increased patient involvement in managing diabetes.

Regional Insights

North America is expected to lead the CGM market in 2024, accounting for over 42.2% of the global market share. Key factors contributing to this dominance include the high level of patient engagement, the shift towards preventive care, strong awareness about CGM devices, and the availability of reimbursement options in developed countries. For example, a study conducted by One Drop, a U.S.-based precision health company, found that approximately 2.4 million people in the U.S. used CGM devices in 2022, a number that is expected to grow significantly over the coming years, further expanding the U.S. market share.

Conclusion

The continuous glucose monitoring market is poised for substantial growth over the forecast period, driven by technological innovations, rising health awareness, and the growing prevalence of diabetes worldwide. With strong support from key players and increasing accessibility in emerging regions, the CGM market will continue to play a critical role in diabetes management globally.

Buy Now: https://www.meticulousresearch.com/Checkout/64947495

Contact Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research